October 23, 2007 – Boston Scientific Corp. announced five-year and final follow-up data from its TAXUS IV clinical trial ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
Cordis Corp. introduced next generation carotid stent system, the PRECISE PRO RX Nitinol Self-Expanding Stent ...
October 25, 2007 - Cordis Corp. announced at TCT 2007 the U.S. and European launch of Cordis’s next generation ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
October 25, 2007 — Two carotid stenting trials examining outcomes in real-world patients demonstrated for the ...
October 24, 2007 - Presented at the TCT 2007 meeting, a pooled analysis of safety data from Medtronic’s ENDEAVOR ...
October 25, 2007 - Paieon Inc. demonstrated at TCT 2007 the CardiOp-StentOptimizer, a real-time imaging solution ...
October 25, 2007 - Global Therapeutics, a Cook Medical company, said at TCT 2007 it will begin a clinical trial using ...
OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...
October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to ...
October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent ...
October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac ...
October 22, 2007 - Implantation of the CYPHER Sirolimus-eluting Coronary Stent by Cordis Corp. used to treat completely ...
October 22, 2007 – Stent thrombosis rates through one year were low for both the TAXUS Express2 Paclitaxel-Eluting ...
October 18, 2007 – XTENT Inc. announced that two-year data from the CUSTOM I trial and 1-year data from the CUSTOM II ...
October 18, 2007 - Cordis Corp. will present clinical data backing the CYPHER Sirolimus-eluting coronary stent at the ...